Background To estimate the potential cost savings by following the current Global Initiative
for Chronic Obstructive Lung Disease (GOLD) guideline recommendations in patients being …

Exacerbations, which often lead to emergency department visits and hospitalizations, are
the main drivers of morbidity and utilization of health care resources among patients with …

Background and objective While several studies have found that prescribing practices do
not conform to chronic obstructive pulmonary disease (COPD) treatment guidelines, none …

Purpose Clinical guidelines for COPD management suggest pharmacologic treatment
algorithms based on symptoms and exacerbation history. As previous research has …

This review addresses outstanding questions regarding initial pharmacological
management of chronic obstructive pulmonary disease (COPD). Optimizing initial treatment …

Background Ideally, treatment recommendations for maintenance therapy-naïve patients
with COPD should be based on studies conducted specifically in this population. We have …

Background To assess the symptomatic and cost burden among patients initiating long-
acting bronchodilator (LABD) therapy and impact of adherence on healthcare resource use …

Objective: To compare the available literature regarding the use of long-acting muscarinic
antagonist (LAMA)/long-acting β2 agonists (LABA) and inhaled corticosteroid (ICS)/LABA …

Long-acting muscarinic antagonist (LAMA) or long-acting β2-agonist (LABA) bronchodilators
and their combination are recommended for the maintenance treatment of chronic …

Background: Long-acting muscarinic antagonists (LAMAs) and long-acting β2–agonists
(LABAs) are the mainstay of maintenance therapy for chronic obstructive pulmonary disease …